Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data

INTRODUCTION: The risk for development of a second primary lung cancer (SPLC) after treatment of an initial primary lung cancer (IPLC) is around 1% to 2% per patient per year. The present screening and surveillance guidelines do not adequately address this particular patient population. METHODS: We...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Thorac Oncol
Asıl Yazarlar: Thakur, Manish K., Ruterbusch, Julie J., Schwartz, Ann G., Gadgeel, Shirish M., Beebe-Dimmer, Jennifer L., Wozniak, Antoinette J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6108174/
https://ncbi.nlm.nih.gov/pubmed/28989038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2017.09.1964
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller